
Opinion|Videos|December 12, 2024
Safety, Efficacy, and Treatment Adherence in Young Patients With Vitiligo
Author(s)Karan Lal, DO, MS, FAAD
Key Takeaways
Karan Lal, DO, MS, FAAD, discusses how to balance safety and efficacy considerations while promoting treatment adherence in young vitiligo patients, focusing on the unique challenges and monitoring requirements for this vulnerable population.
Advertisement
Episodes in this series

Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows
2
New Phase 3 DISCREET Data Supports Long-Term Use of Apremilast for Genital Psoriasis
3
Rethinking Aging in Skin of Color: A Pigment-First Approach
4
Phase 3 Results Signal a New Era for Oral Targeted Therapy in Psoriasis
5












